Vellonen KS - Search Results

1

Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.

Sjöstedt N, Kortejärvi H, Kidron H, Vellonen KS, Urtti A, Yliperttula M. Sjöstedt N, et al. Among authors: vellonen ks. Pharm Res. 2014 Jan;31(1):1-19. doi: 10.1007/s11095-013-1124-2. Pharm Res. 2014. PMID: 23797466 Review.

2

Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model.

Toropainen E, Ranta VP, Vellonen KS, Palmgrén J, Talvitie A, Laavola M, Suhonen P, Hämäläinen KM, Auriola S, Urtti A. Toropainen E, et al. Among authors: vellonen ks. Eur J Pharm Sci. 2003 Sep;20(1):99-106. doi: 10.1016/s0928-0987(03)00173-8. Eur J Pharm Sci. 2003. PMID: 13678798

3

Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells.

Ranta VP, Laavola M, Toropainen E, Vellonen KS, Talvitie A, Urtti A. Ranta VP, et al. Among authors: vellonen ks. Pharm Res. 2003 Sep;20(9):1409-16. doi: 10.1023/a:1025754026449. Pharm Res. 2003. PMID: 14567635

4

Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity.

Vellonen KS, Honkakoski P, Urtti A. Vellonen KS, et al. Eur J Pharm Sci. 2004 Oct;23(2):181-8. doi: 10.1016/j.ejps.2004.07.006. Eur J Pharm Sci. 2004. PMID: 15451006

5

Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics.

Mannermaa E, Vellonen KS, Urtti A. Mannermaa E, et al. Among authors: vellonen ks. Adv Drug Deliv Rev. 2006 Nov 15;58(11):1136-63. doi: 10.1016/j.addr.2006.07.024. Epub 2006 Sep 16. Adv Drug Deliv Rev. 2006. PMID: 17081648 Review.

6

Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines.

Siissalo S, Laitinen L, Koljonen M, Vellonen KS, Kortejärvi H, Urtti A, Hirvonen J, Kaukonen AM. Siissalo S, et al. Among authors: vellonen ks. Eur J Pharm Biopharm. 2007 Sep;67(2):548-54. doi: 10.1016/j.ejpb.2007.03.017. Epub 2007 Mar 28. Eur J Pharm Biopharm. 2007. PMID: 17475454

7

Efflux protein expression in human retinal pigment epithelium cell lines.

Mannermaa E, Vellonen KS, Ryhänen T, Kokkonen K, Ranta VP, Kaarniranta K, Urtti A. Mannermaa E, et al. Among authors: vellonen ks. Pharm Res. 2009 Jul;26(7):1785-91. doi: 10.1007/s11095-009-9890-6. Epub 2009 Apr 21. Pharm Res. 2009. PMID: 19384462

8

Effluxing ABC transporters in human corneal epithelium.

Vellonen KS, Mannermaa E, Turner H, Häkli M, Wolosin JM, Tervo T, Honkakoski P, Urtti A. Vellonen KS, et al. J Pharm Sci. 2010 Feb;99(2):1087-98. doi: 10.1002/jps.21878. J Pharm Sci. 2010. PMID: 19623615 Free PMC article.

9

Monocarboxylate transport in human corneal epithelium and cell lines.

Vellonen KS, Häkli M, Merezhinskaya N, Tervo T, Honkakoski P, Urtti A. Vellonen KS, et al. Eur J Pharm Sci. 2010 Feb 19;39(4):241-7. doi: 10.1016/j.ejps.2009.12.006. Epub 2009 Dec 24. Eur J Pharm Sci. 2010. PMID: 20035863

10

Filter-cultured ARPE-19 cells as outer blood-retinal barrier model.

Mannermaa E, Reinisalo M, Ranta VP, Vellonen KS, Kokki H, Saarikko A, Kaarniranta K, Urtti A. Mannermaa E, et al. Among authors: vellonen ks. Eur J Pharm Sci. 2010 Jul 11;40(4):289-96. doi: 10.1016/j.ejps.2010.04.001. Epub 2010 Apr 10. Eur J Pharm Sci. 2010. PMID: 20385230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters